Background: Although most patients do not develop hypersensitivity reactions to metals in implanted devices, when they do occur, significant morbidity can result. Titanium-based systems are often considered as an alternative option in metal-allergic patients; however, there are few studies published on titanium allergy and allergic reactions to titanium in implants may be overlooked in clinical practice.
Methods: Our aim was to further characterize a single institution's experience with titanium patch testing and evaluation of titanium allergy. We performed a retrospective medical record review of 166 patients evaluated for titanium contact allergy between January 2018-August 2023. Of the 166 patients in our cohort, 67 were referred for pre-implant patch testing and 64 for post-implant patch testing; 35 were tested for reasons unrelated to an implant.
Results: Twenty-six of the 166 patients were PTP to titanium (15.7% positive rate). Titanium PTP rates were higher for post-implant cases (28.1%, 18/64) compared to pre-implant cases (6.0%, 4/67) (χ2 9.97, p = 0.002). Among 18 titanium PTPs identified for the 64 post-implant cases, 8 were likely relevant, 8 possibly relevant, and 2 not likely relevant.
Conclusions: Further studies should be performed to evaluate the incidence of allergy to titanium implants and to continue surveillance of changes in sensitization rates.
Get full access to this article
View all access options for this article.
References
1.
WoodMM, WarshawEM. Hypersensitivity reactions to titanium: diagnosis and management. Dermatitis®. 2015; 26(1):7–25.
2.
de GraafNPJ, FeilzerAJ, KleverlaanCJ, et al.A retrospective study on titanium sensitivity: patch test materials and manifestations. Contact Dermatitis®. 2018; 79(2):85–90.
3.
TamI, YuJ, KoLN, et al.Patch testing with an extended metal allergen series at the Massachusetts General Hospital (2006–2017). Dermatitis®. 2020; 31(6):359–366.
4.
SchalockPC, CrawfordG, NedorostS, et al.Patch testing for evaluation of hypersensitivity to implanted metal devices: a perspective from the American Contact Dermatitis® Society. Dermatitis®. 2016; 27(5):241–247.
5.
FageSW, MurisJ, JakobsenSS, et al.Titanium: a review on exposure, release, penetration, allergy, epidemiology, and clinical reactivity. Contact Dermatitis®. 2016; 74(6):323–345.
